Legend Biotech Corporation

NASDAQ:LEGN

Biotechnology

Healthcare
$16.10 -13.51%

-$4.53 today

Market cap
$2.98B
Beta
0.35
P/E (TTM)
-21.4
EPS (TTM)
-$1.35
52W Low $16.24High $45.30

Volume 2.37M

Average 2.42M

Income Statement

Follow revenue through to earnings.

Revenue

$1.03B

FY 2025 · Annual

+64.0% YoY

Operating Income

-$136.50M

FY 2025 · Annual

Net Income

-$296.80M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue68.83M117.01M285.14M627.24M1.03B
Cost of Revenue065.36M144.21M234.58M408.1M
Gross Profit68.83M51.64M140.93M392.66M620.8M
Gross Margin100.0%44.1%49.4%62.6%60.3%
Research & Development313.35M335.65M382.22M413.54M414.7M
Selling, General & Admin149.5M174.05M200.93M284.26M341.6M
Operating Expenses461.11M507.26M580.41M695.9M757.3M
Depreciation & Amortization13.92M18.39M20.45M23.36M28.9M
EBITDA(392.38M)(416.54M)(477.87M)(113.16M)(232.3M)
EBITDA Margin-570.1%-356.0%-167.6%-18.0%-22.6%
Operating Income(392.29M)(455.62M)(439.49M)(303.24M)(136.5M)
Operating Margin-570.0%-389.4%-154.1%-48.3%-13.3%
Interest Income971K8.18M54.49M61.2M40.1M
Interest Expense900K10.8M21.79M21.62M21.4M
Other Income / Expenses(14.91M)9.9M(80.63M)145.11M(146.1M)
Income Before Tax(407.2M)(445.72M)(520.12M)(158.13M)(282.6M)
Pre-Tax Margin-591.6%-380.9%-182.4%-25.2%-27.5%
Income Tax Expense(3.61M)625K(1.86M)18.89M14.2M
Net Income(403.58M)(446.35M)(518.25M)(177.03M)(296.8M)
Net Margin-586.4%-381.5%-181.8%-28.2%-28.8%
EPS (Basic)(2.74)(2.81)(2.94)(0.97)(1.60)
EPS (Diluted)(2.74)(2.81)(2.94)(0.97)(1.60)
Weighted Avg Shares140.85M159.04M176.08M182.85M184.32M
Weighted Avg Shares (Diluted)140.85M159.04M176.08M182.85M184.32M

LEGN Earnings Waterfall · TTM

NASDAQ:LEGN · Revenue to Net Income

Key Ratios

EPS$-0.03
Gross Margin56.4%
Net Margin-1.2%
P/E Ratio2.7
P/S Ratio12.1

Analysis

$1.4B of revenue converted into -$215.0K of net income for the selected period. Gross margin is 56.4% and net margin is -1.2%, showing how much revenue survives after costs and taxes. EPS is $-0.03, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 10, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
6-K6-K filingNov 4, 2026
6-K6-K filingOct 15, 2026
6-K6-K filingOct 13, 2026

How much revenue does LEGN generate?

Legend Biotech Corporation (LEGN) reported $1.03B of revenue in fiscal 2025.

Is LEGN profitable?

Legend Biotech Corporation (LEGN) reported -$296.80M of net income, with a net margin of -28.8%.